Yale Cancer Center researchers have identified several effective combinations of therapies that inhibit melanomas driven by two of the most formidable cancer genes. Some combinations include cholesterol-lowering statin drugs. The study appears in the journal Cancer Discovery. Read more here.
Study mentioned: Held MA, et al. Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening. Cancer Discov. 2012 Dec 13. [Epub ahead of print] PMID: 23239741
No comments:
Post a Comment